## Abstract The use of mammalian cells as substrates for the production of various vaccines is a timeβhonored procedure. With the advent of recombinant DNA technology, various investigators soon realized that these techniques could be applied to mammalian cells to convert them to reliable, safe pro
β¦ LIBER β¦
Use of recombinant mammalian cell lines for vaccine production
β Scribed by Patzer, Eric J.; Lasky, Laurence A.
- Book ID
- 123095589
- Publisher
- Elsevier Science
- Year
- 1984
- Tongue
- English
- Weight
- 135 KB
- Volume
- 2
- Category
- Article
- ISSN
- 0264-410X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
From virus to vaccine: Recombinant mamma
β
Laurence A. Lasky
π
Article
π
1990
π
John Wiley and Sons
π
English
β 337 KB
Advances in Mammalian Cell Line Developm
β
Lai, Tingfeng; Yang, Yuansheng; Ng, Say
π
Article
π
2013
π
MDPI AG
π
English
β 476 KB
Mammalian Cell Culture Systems for Recom
β
J.R. Birch; S.J. Froud
π
Article
π
1994
π
Elsevier Science
π
English
β 368 KB
[Methods in Molecular Biology] Recombina
β
Lorence, Argelia
π
Article
π
2011
π
Humana Press
β 520 KB
[Cell Engineering] Cell Line Development
β
Al-Rubeai, Mohamed
π
Article
π
2009
π
Springer Netherlands
π
Dutch
β 646 KB
Mammalian cell lines command an effective monopoly for the production of therapeutic proteins that require post-translational modifications. This unique advantage outweighs the costs associated with mammalian cell culture, which are far grater in terms of development time and manufacturing when comp
Vaccines, cells, and nucleic acids: Work
β
Prof. Arie J. Zuckerman
π
Article
π
1990
π
John Wiley and Sons
π
English
β 101 KB